XBIO Stock Analysis: Buy, Sell, or Hold?
XBIO - Xenetic Biosciences, Inc.
$2.22
-0.11 (-4.72%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 17, 2026
Get Alerted When XBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XBIO is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: XBIO is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: XBIO is currently trading at $2.22, which is considered fair relative to its 30-day fair value range of $2.11 to $2.48.
Technical Outlook: Technically, XBIO is in a downtrend. The price is currently testing key support at $2.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: XBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.00 (+1616.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XBIO is in a downtrend. The price is currently testing key support at $2.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: XBIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.00 (+1616.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.11 -
$2.48
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
Protect Your Profits
Holding XBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 1616.7% below Wall St target ($40.00)
- WARNING: Recommendation downgraded due to -16.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.11 -
$2.48
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.20
Resistance Level
$2.79
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$40.00
(+1616.7%)
Revenue Growth (YoY)
67.2%
Profit Margin
-110.4%
Last updated: January 30, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
Data refreshes hourly during market hours. Next update: 6:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced XBIO Option Strategies
Professional options setups generated by AI based on today's XBIO price and gamma walls.
